Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo De Giorgio

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Digestive Diseases and Sciences|April 6, 2011
Small HCCs identified by screeningPetr Pancoska, Massimo De Giorgio, Stefano Fagiuoli, et al.
Oncology|September 26, 2012
Small hepatocellular carcinomas and thrombocytopeniaBrian I Carr, Vito Guerra, Massimo De Giorgio, et al.
Expert Review of Anticancer Therapy|November 5, 2011
Management of cirrhotic patients with hepatocellular carcinoma treated with sorafenibGiuseppe Cabibbo, Emanuela Rolle, Massimo De Giorgio, et al.
Cancers|March 29, 2023
Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for CancerMauro Viganò, Marta La Milia, Maria Vittoria Grassini, et al.
Journal of Hepatology|May 16, 2020
Health status of patients with autoimmune liver disease during SARS-CoV-2 outbreak in northern ItalyAngelo Di Giorgio, Emanuele Nicastro, Camilla Speziani, et al.
Cancers|December 10, 2021
Pre-Transplant Alpha-Fetoprotein > 25.5 and Its Dynamic on Waitlist Are Predictors of HCC Recurrence after Liver Transplantation for Patients Meeting Milan CriteriaBianca Magro, Domenico Pinelli, Massimo De Giorgio, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 8, 2010
Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteriaMassimo De Giorgio, Stefano Vezzoli, Eric Cohen, et al.
The American Journal of Gastroenterology|March 18, 2006
Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?Fabio Farinati, Dario Marino, Massimo De Giorgio, et al.
Future Oncology (London, England)|March 27, 2018
Treatment of hepatocellular carcinoma: a cost analysis of yttrium-90 transarterial radioembolization versus sorafenibMaria Grazia Lucà, Roberto Nani, Melanie Schranz, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|May 10, 2025
Dosimetric optimization and evaluation of hepatocellular carcinoma treatment effect prediction in Y-90 radioembolizationLaura Grikke, Massimo De Giorgio, Claudia Bianchi, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Digestive Diseases and Sciences|April 6, 2011
Small HCCs identified by screeningPetr Pancoska, Massimo De Giorgio, Stefano Fagiuoli, et al.
Oncology|September 26, 2012
Small hepatocellular carcinomas and thrombocytopeniaBrian I Carr, Vito Guerra, Massimo De Giorgio, et al.
Expert Review of Anticancer Therapy|November 5, 2011
Management of cirrhotic patients with hepatocellular carcinoma treated with sorafenibGiuseppe Cabibbo, Emanuela Rolle, Massimo De Giorgio, et al.
Cancers|March 29, 2023
Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for CancerMauro Viganò, Marta La Milia, Maria Vittoria Grassini, et al.
Journal of Hepatology|May 16, 2020
Health status of patients with autoimmune liver disease during SARS-CoV-2 outbreak in northern ItalyAngelo Di Giorgio, Emanuele Nicastro, Camilla Speziani, et al.
Cancers|December 10, 2021
Pre-Transplant Alpha-Fetoprotein > 25.5 and Its Dynamic on Waitlist Are Predictors of HCC Recurrence after Liver Transplantation for Patients Meeting Milan CriteriaBianca Magro, Domenico Pinelli, Massimo De Giorgio, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 8, 2010
Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteriaMassimo De Giorgio, Stefano Vezzoli, Eric Cohen, et al.
The American Journal of Gastroenterology|March 18, 2006
Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?Fabio Farinati, Dario Marino, Massimo De Giorgio, et al.
Future Oncology (London, England)|March 27, 2018
Treatment of hepatocellular carcinoma: a cost analysis of yttrium-90 transarterial radioembolization versus sorafenibMaria Grazia Lucà, Roberto Nani, Melanie Schranz, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|May 10, 2025
Dosimetric optimization and evaluation of hepatocellular carcinoma treatment effect prediction in Y-90 radioembolizationLaura Grikke, Massimo De Giorgio, Claudia Bianchi, et al.
Pageof 2